| Product Code: ETC7904523 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia saw a steady growth in antivirals import shipments, with top exporting countries being Lithuania, Netherlands, Switzerland, Poland, and Germany. The market remained competitive with low concentration as indicated by the Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) for the period 2020-2024 stood at a healthy 8.6%, while the growth rate from 2023 to 2024 was 7.03%, showcasing a positive trend in the Latvian antivirals market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Antivirals Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Antivirals Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Antivirals Market - Industry Life Cycle |
3.4 Latvia Antivirals Market - Porter's Five Forces |
3.5 Latvia Antivirals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Antivirals Market Revenues & Volume Share, By Actions, 2021 & 2031F |
4 Latvia Antivirals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Latvia |
4.2.2 Growing awareness about the importance of antiviral medications |
4.2.3 Technological advancements in antiviral drug development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Latvia |
4.3.2 High cost associated with antiviral medications |
4.3.3 Limited accessibility to healthcare services in certain regions of Latvia |
5 Latvia Antivirals Market Trends |
6 Latvia Antivirals Market, By Types |
6.1 Latvia Antivirals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Antivirals Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2021- 2031F |
6.1.4 Latvia Antivirals Market Revenues & Volume, By HIV antivirals, 2021- 2031F |
6.1.5 Latvia Antivirals Market Revenues & Volume, By Herpes antivirals, 2021- 2031F |
6.1.6 Latvia Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2021- 2031F |
6.1.7 Latvia Antivirals Market Revenues & Volume, By Influenza antivirals, 2021- 2031F |
6.1.8 Latvia Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Latvia Antivirals Market, By Actions |
6.2.1 Overview and Analysis |
6.2.2 Latvia Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2021- 2031F |
6.2.3 Latvia Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2021- 2031F |
6.2.4 Latvia Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.5 Latvia Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Antivirals Market Import-Export Trade Statistics |
7.1 Latvia Antivirals Market Export to Major Countries |
7.2 Latvia Antivirals Market Imports from Major Countries |
8 Latvia Antivirals Market Key Performance Indicators |
8.1 Number of new antiviral drug approvals in Latvia |
8.2 Adoption rate of antiviral medications among healthcare providers in Latvia |
8.3 Research and development investment in antiviral drugs in Latvia |
9 Latvia Antivirals Market - Opportunity Assessment |
9.1 Latvia Antivirals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Antivirals Market Opportunity Assessment, By Actions, 2021 & 2031F |
10 Latvia Antivirals Market - Competitive Landscape |
10.1 Latvia Antivirals Market Revenue Share, By Companies, 2024 |
10.2 Latvia Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here